SAB Biotherapeutics, Inc. — Form D

SAB Biotherapeutics, Inc. of Miami Beach, FL, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-05. The offering totals $175.0M, of which $175.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Katie ElliasDirectorMiami Beach, FL
Scott GibersonDirectorMiami Beach, FL
Christine HamiltonDirectorMiami Beach, FL
David LinkDirectorMiami Beach, FL
Erick LuceraDirectorMiami Beach, FL
Andrew MoinDirectorMiami Beach, FL
William PolvinoDirectorMiami Beach, FL
Samuel ReichDirectorMiami Beach, FL
Jay SkylerDirectorMiami Beach, FL
Jeffrey SpragensDirectorMiami Beach, FL
Eddie SullivanDirectorMiami Beach, FL
Samuel ReichExecutive OfficerMiami Beach, FL
Eddie SullivanExecutive OfficerMiami Beach, FL
Russell J BeyerExecutive OfficerSioux Falls, SD
Erick Charles LuceraDirectorSioux Falls, SD
David Charles LinkDirectorSioux Falls, SD
Eddie J SullivanDirectorSioux Falls, SD
Eddie J SullivanExecutive OfficerSioux Falls, SD
William Charles PolvinoDirectorSioux Falls, SD
Christine J HamiltonDirectorSioux Falls, SD
Scott J GibersonDirectorSioux Falls, SD
Andrew G MoinDirectorSioux Falls, SD
Jeffrey G SpragensDirectorSioux Falls, SD
SAMUEL J REICHDirectorMIAMI BEACH, FL
SAMUEL J REICHExecutive OfficerMIAMI BEACH, FL

Other filings by this issuer (1)

FiledFormOfferingSold
2023-10-16D$7.5M$7.5M

More